Yunfeng Cao
Research Subjects
Research Interests
Yunfeng Cao has a total of 196 co-authors. Here are the top co-authors by number of shared publications:
Furong Zhao
Liaoning Provincial Key Laboratory of Clinical Oncology Metabonomics, Jinzhou Medical University, Jinzhou 121001, China
6 shared publicationsXueting Cui
Dalian Boyuan Medical Technology Co, Ltd, Dalian, China
5 shared publicationsXiaoyu Sun
Dalian Boyuan Medical Technology Co, Ltd, Dalian, China
4 shared publications- Zhong-Ze Fang
Department of Toxicology and Sanitary Chemistry, School of Public Health, Tianjin Medical University, Tianjin, China
4 shared publications Mingli Liu
Dalian Boyuan Medical Technology Co., Ltd , Dalian , P.R. China
3 shared publicationsShuang Wang
Clinical research department, Dalian Boyuan Medical Technology Co., Ltd, Dalian, China; Department of medical Research, Dalian Runsheng Kangtai Medical Lab Co. Ltd, Dalian, China
3 shared publications
Latest Publications
- Open Access
- 2 October 2025
- Published by Springer Nature in BMC Pediatrics
- Vol. 25 (1) , 1-8
Association of IGF-1 with hypertension among children and adolescents
Hypertension among children and adolescents is an escalating global health issue, significantly linked to cardiovascular risks and long-term complications in adulthood. Insulin-like growth factor 1 (IGF-1) is recognized for its role in growth and metabolism, yet its relationship with pediatric hypertension remains poorly understood. This study aimed to explore the association between IGF-1 levels and hypertension in children and adolescents. Participants were categorized into Normal and Hypertension groups based on hypertension criteria. Demographic, anthropometric, and laboratory data were collected via medical records. Logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs). Data from 586 participants were analyzed. The prevalence of hypertension was 22.3% among the participants. Lower IGF-1 levels were significantly associated with an increased risk of hypertension. Compared to the highest quartile of IGF-1, the adjusted odds ratios (OR) for hypertension were 6.99 for quartiles 1 (p < 0.05). The association was more pronounced in females, children aged 6–12 years, and those with abdominal obesity. Lower IGF-1 levels are significantly associated with an increased risk of hypertension in children and adolescents. This association is evident across different subgroups, including sex, age, and obesity status. These findings highlight Maintaining the balance of these factors is critical for hypertension health, especially during adolescence.
- 2 October 2025
- Published by Springer Nature in BMC Pediatrics
- Vol. 25 (1) , 1-8
Open AccessAssociation of IGF-1 with hypertension among children and adolescents
Hypertension among children and adolescents is an escalating global health issue, significantly linked to cardiovascular risks and long-term complications in adulthood. Insulin-like growth factor 1 (IGF-1) is recognized for its role in growth and metabolism, yet its relationship with pediatric hypertension remains poorly understood. This study aimed to explore the association between IGF-1 levels and hypertension in children and adolescents. Participants were categorized into Normal and Hypertension groups based on hypertension criteria. Demographic, anthropometric, and laboratory data were collected via medical records. Logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs). Data from 586 participants were analyzed. The prevalence of hypertension was 22.3% among the participants. Lower IGF-1 levels were significantly associated with an increased risk of hypertension. Compared to the highest quartile of IGF-1, the adjusted odds ratios (OR) for hypertension were 6.99 for quartiles 1 (p < 0.05). The association was more pronounced in females, children aged 6–12 years, and those with abdominal obesity. Lower IGF-1 levels are significantly associated with an increased risk of hypertension in children and adolescents. This association is evident across different subgroups, including sex, age, and obesity status. These findings highlight Maintaining the balance of these factors is critical for hypertension health, especially during adolescence.
- Open Access
- 1 February 2025
- Published by China Science Publishing & Media Ltd. in Chinese Journal of Chromatography
- Vol. 43 (2) , 148-154
Determination of three metabolites of thromboxane A2 and 8-iso-prostaglandin F2α in urine by ultra performance liquid chromatography-tandem mass spectrometry
Thromboxane A2 (TXA2), a prothrombotic factor that induces platelet aggregation and thrombosis, acts as a vasoconstrictor by activating TXA2 receptors (TP receptors). TXA2 is extremely unstable and metabolizes into three major metabolites: 2,3-dinor thromboxane B2 (2,3-dinor-TXB2), 11-dehydro TXB2(11-dh-TXB2), and 11-dehydro-2,3-dinor TXB2(11-dh-2,3-dinor-TXB2). 8-Iso-prostaglandin F2α(8-iso-PGF2α), a prostaglandin-like compound widely considered the best biomarker of oxidative stress, can also activate TP receptors. The accurate quantification of TXA2 metabolites and 8-iso-PGF2α is critical in cardiovascular disease (CVD). In this study, a method based on ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was developed for the simultaneous determination of 2,3-dinor-TXB2,11-dh-2,3-dinor-TXB2, 11-dh-TXB2, and 8-iso-PGF2α in human urine. Urine samples were collected from healthy volunteers and patients with CT- or MRI-confirmed ischemic stroke occurring less than 48 h earlier, and cryopreserved at -80 ℃ within 1 h after collection. The urine samples were thawed at room temperature and acidified to pH 2.0-4.0 using hydrochloric acid. The supernatant was collected after centrifugation. A total of 1 mL of each urine sample was added with 100 μL of the internal standard working solution and mixed well. The samples were loaded onto a C18 SPE column (50 mg). The SPE cartridges were preconditioned with 500 μL of methanol and then equilibrated with 500 μL of water. After sample loading, the SPE cartridges were washed with 500 μL of water, 500 μL of 5% methanol aqueous solution containing 0.5% (v/v) ammonia, and 500 μL of 5% methanol aqueous solution containing 2% (v/v) formic acid. The cartridges were dried, and the analytes were eluted with 400 μL of methanol. The eluents were dried and subsequently reconstituted with 50 μL of 13% acetonitrile aqueous solution. After filtration through a filter membrane, the samples were analyzed on an ACQUITY UPLC® BEH phenyl column (50 mm×2.1 mm, 1.7 μm) via gradient elution using 2 mmol/L ammonium acetate aqueous solution containing 0.002% (v/v) ammonia and acetonitrile as the mobile phases. The flow rate was 0.3 mL/min, and the column temperature was 40 ℃. The analytes were determined in negative electrospray ionization and multiple-reaction monitoring modes. The four target compounds showed satisfactory linearity within the relevant ranges, with linear correlation coefficients (R2) greater than 0.99. The limits of detection of the method were 0.02 ng/mL for 2,3-dinor-TXB2 and 0.01 ng/mL for 11-dh-2,3-dinor-TXB2, 11-dh-TXB2, and 8-iso-PGF2α. The limits of quantification were 0.1 ng/mL for 2,3-dinor-TXB2 and 0.05 ng/mL for 11-dh-2,3-dinor-TXB2, 11-dh-TXB2, and 8-iso-PGF2α. In actual urine, the recovery rates at the LOQ level were in the range of 91.48%-104.87%. The recovery rates at low, medium, and high levels were in the range of 92.95%-104.90%. The intra- and inter-day precisions were in the range of 2.79%-13.01% and 4.45%-13.67%, respectively. The relative error (RE) between the average peak area of the mixed matrix and the sum of the ratios of the pure solution and urine matrices was within ±20%. The samples were stable at 4 ℃ for 24 h and at -70 ℃ for 10 d. The developed method is the first to realize the simultaneous determination of 2,3-dinor-TXB2, 11-dh-2,3-dinor-TXB2, 11-dh-TXB2, and 8-iso-PGF2α in urine. The method was used to determine the concentrations of 2,3-dinor-TXB2, 11-dh-2,3-dinor-TXB2, 11-dh-TXB2, and 8-iso-PGF2α in healthy controls and patients with ischemic stroke, and the results were corrected using creatinine. Binary logistic regression analysis was used to construct the prediction model, and a receiver operating characteristic (ROC) curve was drawn to evaluate the clinical diagnostic ability of the method for the target compounds. TXA2 was calculated as the sum of its three metabolites. The area under the curve (AUC) of TXA2 was 0.849, and the method sensitivity and specificity were 69.2% and 92.3%, respectively. The AUC of 8-iso-PGF2α was 0.775, and the method sensitivity and specificity were 84.6% and 76.9%, respectively. The proposed method has good clinical value and is expected to assist in the early screening and diagnosis of ischemic stroke.
- 1 February 2025
- Published by China Science Publishing & Media Ltd. in Chinese Journal of Chromatography
- Vol. 43 (2) , 148-154
Open AccessDetermination of three metabolites of thromboxane A2 and 8-iso-prostaglandin F2α in urine by ultra performance liquid chromatography-tandem mass spectrometry
Thromboxane A2 (TXA2), a prothrombotic factor that induces platelet aggregation and thrombosis, acts as a vasoconstrictor by activating TXA2 receptors (TP receptors). TXA2 is extremely unstable and metabolizes into three major metabolites: 2,3-dinor thromboxane B2 (2,3-dinor-TXB2), 11-dehydro TXB2(11-dh-TXB2), and 11-dehydro-2,3-dinor TXB2(11-dh-2,3-dinor-TXB2). 8-Iso-prostaglandin F2α(8-iso-PGF2α), a prostaglandin-like compound widely considered the best biomarker of oxidative stress, can also activate TP receptors. The accurate quantification of TXA2 metabolites and 8-iso-PGF2α is critical in cardiovascular disease (CVD). In this study, a method based on ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was developed for the simultaneous determination of 2,3-dinor-TXB2,11-dh-2,3-dinor-TXB2, 11-dh-TXB2, and 8-iso-PGF2α in human urine. Urine samples were collected from healthy volunteers and patients with CT- or MRI-confirmed ischemic stroke occurring less than 48 h earlier, and cryopreserved at -80 ℃ within 1 h after collection. The urine samples were thawed at room temperature and acidified to pH 2.0-4.0 using hydrochloric acid. The supernatant was collected after centrifugation. A total of 1 mL of each urine sample was added with 100 μL of the internal standard working solution and mixed well. The samples were loaded onto a C18 SPE column (50 mg). The SPE cartridges were preconditioned with 500 μL of methanol and then equilibrated with 500 μL of water. After sample loading, the SPE cartridges were washed with 500 μL of water, 500 μL of 5% methanol aqueous solution containing 0.5% (v/v) ammonia, and 500 μL of 5% methanol aqueous solution containing 2% (v/v) formic acid. The cartridges were dried, and the analytes were eluted with 400 μL of methanol. The eluents were dried and subsequently reconstituted with 50 μL of 13% acetonitrile aqueous solution. After filtration through a filter membrane, the samples were analyzed on an ACQUITY UPLC® BEH phenyl column (50 mm×2.1 mm, 1.7 μm) via gradient elution using 2 mmol/L ammonium acetate aqueous solution containing 0.002% (v/v) ammonia and acetonitrile as the mobile phases. The flow rate was 0.3 mL/min, and the column temperature was 40 ℃. The analytes were determined in negative electrospray ionization and multiple-reaction monitoring modes. The four target compounds showed satisfactory linearity within the relevant ranges, with linear correlation coefficients (R2) greater than 0.99. The limits of detection of the method were 0.02 ng/mL for 2,3-dinor-TXB2 and 0.01 ng/mL for 11-dh-2,3-dinor-TXB2, 11-dh-TXB2, and 8-iso-PGF2α. The limits of quantification were 0.1 ng/mL for 2,3-dinor-TXB2 and 0.05 ng/mL for 11-dh-2,3-dinor-TXB2, 11-dh-TXB2, and 8-iso-PGF2α. In actual urine, the recovery rates at the LOQ level were in the range of 91.48%-104.87%. The recovery rates at low, medium, and high levels were in the range of 92.95%-104.90%. The intra- and inter-day precisions were in the range of 2.79%-13.01% and 4.45%-13.67%, respectively. The relative error (RE) between the average peak area of the mixed matrix and the sum of the ratios of the pure solution and urine matrices was within ±20%. The samples were stable at 4 ℃ for 24 h and at -70 ℃ for 10 d. The developed method is the first to realize the simultaneous determination of 2,3-dinor-TXB2, 11-dh-2,3-dinor-TXB2, 11-dh-TXB2, and 8-iso-PGF2α in urine. The method was used to determine the concentrations of 2,3-dinor-TXB2, 11-dh-2,3-dinor-TXB2, 11-dh-TXB2, and 8-iso-PGF2α in healthy controls and patients with ischemic stroke, and the results were corrected using creatinine. Binary logistic regression analysis was used to construct the prediction model, and a receiver operating characteristic (ROC) curve was drawn to evaluate the clinical diagnostic ability of the method for the target compounds. TXA2 was calculated as the sum of its three metabolites. The area under the curve (AUC) of TXA2 was 0.849, and the method sensitivity and specificity were 69.2% and 92.3%, respectively. The AUC of 8-iso-PGF2α was 0.775, and the method sensitivity and specificity were 84.6% and 76.9%, respectively. The proposed method has good clinical value and is expected to assist in the early screening and diagnosis of ischemic stroke.
- Open Access
- 21 June 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (7) , 817
Silkworm Cocoon: Dual Functions as a Traditional Chinese Medicine and the Raw Material of Promising Biocompatible Carriers
The silkworm cocoon (SC), both as a traditional Chinese medicine and as the raw material for biocompatible carriers, has been extensively used in the medical and biomedical fields. This review elaborates on the multiple functions of SC, with an in-depth analysis of its chemical composition, biological activities, as well as its applications in modern medicine. The primary chemical components of SC include silk fibroin (SF), silk sericin (SS), and other flavonoid-like bioactive compounds demonstrating various biological effects. These include hypoglycemic, cardioprotective, hypolipidemic, anti-inflammatory, antioxidant, and antimicrobial actions, which highlight its potential therapeutic benefits. Furthermore, the review explores the applications of silk-derived materials in drug delivery systems, tissue engineering, regenerative medicine, and in vitro diagnostics. It also highlights the progression of SC from laboratory research to clinical trials, emphasizing the safety and efficacy of SC-based materials across multiple medical domains. Moreover, we discuss the market products developed from silk proteins, illustrating the transition from traditional uses to contemporary medical applications. This review provides support in understanding the current research status of SC and the further development and application of its derived products.
- 21 June 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (7) , 817
Open AccessSilkworm Cocoon: Dual Functions as a Traditional Chinese Medicine and the Raw Material of Promising Biocompatible Carriers
The silkworm cocoon (SC), both as a traditional Chinese medicine and as the raw material for biocompatible carriers, has been extensively used in the medical and biomedical fields. This review elaborates on the multiple functions of SC, with an in-depth analysis of its chemical composition, biological activities, as well as its applications in modern medicine. The primary chemical components of SC include silk fibroin (SF), silk sericin (SS), and other flavonoid-like bioactive compounds demonstrating various biological effects. These include hypoglycemic, cardioprotective, hypolipidemic, anti-inflammatory, antioxidant, and antimicrobial actions, which highlight its potential therapeutic benefits. Furthermore, the review explores the applications of silk-derived materials in drug delivery systems, tissue engineering, regenerative medicine, and in vitro diagnostics. It also highlights the progression of SC from laboratory research to clinical trials, emphasizing the safety and efficacy of SC-based materials across multiple medical domains. Moreover, we discuss the market products developed from silk proteins, illustrating the transition from traditional uses to contemporary medical applications. This review provides support in understanding the current research status of SC and the further development and application of its derived products.
- 15 April 2024
- Published by Elsevier in Clinica Chimica Acta
- Vol. 558, 119672
Reference interval establishment and correlation research of urine thromboxane metabolites: Unveiling new possibilities in platelet activation
- 15 April 2024
- Published by Elsevier in Clinica Chimica Acta
- Vol. 558, 119672
Reference interval establishment and correlation research of urine thromboxane metabolites: Unveiling new possibilities in platelet activation
- 14 December 2023
- Published by Elsevier in Clinica Chimica Acta
- Vol. 553, 117709
An ultra performance liquid chromatography method for transthyretin variants screening and heart failure assisting diagnosis
- 14 December 2023
- Published by Elsevier in Clinica Chimica Acta
- Vol. 553, 117709
An ultra performance liquid chromatography method for transthyretin variants screening and heart failure assisting diagnosis
- 14 November 2023
- Published by Elsevier in Clinica Chimica Acta
- Vol. 552, 117650
Simultaneous determination of human plasma 5 amino acid neurotransmitters using liquid chromatography-tandem mass spectrometry: Establishment of reference intervals in Chinese adult population and application to patients with schizophrenia
- 14 November 2023
- Published by Elsevier in Clinica Chimica Acta
- Vol. 552, 117650
Simultaneous determination of human plasma 5 amino acid neurotransmitters using liquid chromatography-tandem mass spectrometry: Establishment of reference intervals in Chinese adult population and application to patients with schizophrenia
- Open Access
- 18 September 2023
- Published by Frontiers Media SA in Frontiers in Ecology and Evolution
- Vol. 11, 1240514
Spatial−temporal variation of ecological environment quality and driving factors from 2000 to 2020 in Wuliangsu Lake Basin, Northern China
Due to global climate change and the intensification of human activities, the ecological function of Wuliangsu Lake Basin has been seriously degraded. Obtaining accurate spatial–temporal dynamics of regional ecological environment quality is essential for the evaluation of ecological management and restoration effects. This study assessed the trend changes and drivers of the Remote Sensing Ecological Index (RSEI) in the Wuliangsu Lake Basin from 2000−2020. Firstly, the trend analysis method and hurst index were used to analyze the temporal and spatial variation of RSEI. Then the main factors of RSEI variation were analyzed using meteorological data, integrated nighttime lighting data, and population density data. Overall, the RSEI shows an increasing trend from the west to the east with a rate of 0.0034 year−1 over the last 21 years. The area change of RSEI was 54.22%, 63.80% and 52.43% for 2000−2006, 2007−2013 and 2014−2020, respectively, which indicates that most areas have a stable ecological environment. However, the overall Future Improvement Trend (FIT) area of RSEI is 42.21%, mainly in Dengkou area, Urad Qianqi and central area. This indicates that the RSEI remains stable locally and shows an overall improving trend. The results of the correlation analysis showed that the areas influenced by meteorological and human factors were highly coincident, mainly in Dengkou and northern Linhe areas and Urad Qianqi. Considering the lagging effect of ecological engineering, the sustainable development status of RSEI in the western and eastern regions will maintain an improving trend in the future. Our study confirms the complex relationship between RSEI and meteorological and human activities, which is crucial for the scientific management of watershed ecosystems under the influence of anthropogenic factors.
- 18 September 2023
- Published by Frontiers Media SA in Frontiers in Ecology and Evolution
- Vol. 11, 1240514
Open AccessSpatial−temporal variation of ecological environment quality and driving factors from 2000 to 2020 in Wuliangsu Lake Basin, Northern China
Due to global climate change and the intensification of human activities, the ecological function of Wuliangsu Lake Basin has been seriously degraded. Obtaining accurate spatial–temporal dynamics of regional ecological environment quality is essential for the evaluation of ecological management and restoration effects. This study assessed the trend changes and drivers of the Remote Sensing Ecological Index (RSEI) in the Wuliangsu Lake Basin from 2000−2020. Firstly, the trend analysis method and hurst index were used to analyze the temporal and spatial variation of RSEI. Then the main factors of RSEI variation were analyzed using meteorological data, integrated nighttime lighting data, and population density data. Overall, the RSEI shows an increasing trend from the west to the east with a rate of 0.0034 year−1 over the last 21 years. The area change of RSEI was 54.22%, 63.80% and 52.43% for 2000−2006, 2007−2013 and 2014−2020, respectively, which indicates that most areas have a stable ecological environment. However, the overall Future Improvement Trend (FIT) area of RSEI is 42.21%, mainly in Dengkou area, Urad Qianqi and central area. This indicates that the RSEI remains stable locally and shows an overall improving trend. The results of the correlation analysis showed that the areas influenced by meteorological and human factors were highly coincident, mainly in Dengkou and northern Linhe areas and Urad Qianqi. Considering the lagging effect of ecological engineering, the sustainable development status of RSEI in the western and eastern regions will maintain an improving trend in the future. Our study confirms the complex relationship between RSEI and meteorological and human activities, which is crucial for the scientific management of watershed ecosystems under the influence of anthropogenic factors.
- Open Access
- 3 July 2023
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 133 (13)
Midbrain dopamine oxidation links ubiquitination of glutathione peroxidase 4 to ferroptosis of dopaminergic neurons
- 3 July 2023
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 133 (13)
Open AccessMidbrain dopamine oxidation links ubiquitination of glutathione peroxidase 4 to ferroptosis of dopaminergic neurons
- Open Access
- 15 May 2023
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 133 (10)
Midbrain dopamine oxidation links ubiquitination of glutathione peroxidase 4 to ferroptosis of dopaminergic neurons
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the gradual loss of midbrain dopaminergic neurons in association with aggregation of α-synuclein. Oxidative damage has been widely implicated in this disease, though the mechanisms involved remain elusive. Here, we demonstrated that preferential accumulation of peroxidized phospholipids and loss of the antioxidant enzyme glutathione peroxidase 4 (GPX4) were responsible for vulnerability of midbrain dopaminergic neurons and progressive motor dysfunctions in a mouse model of PD. We also established a mechanism wherein iron-induced dopamine oxidation modified GPX4, thereby rendering it amenable to degradation via the ubiquitin-proteasome pathway. In conclusion, this study unraveled what we believe to be a novel pathway for dopaminergic neuron degeneration during PD pathogenesis, driven by dopamine-induced loss of antioxidant GPX4 activity.
- 15 May 2023
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 133 (10)
Open AccessMidbrain dopamine oxidation links ubiquitination of glutathione peroxidase 4 to ferroptosis of dopaminergic neurons
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the gradual loss of midbrain dopaminergic neurons in association with aggregation of α-synuclein. Oxidative damage has been widely implicated in this disease, though the mechanisms involved remain elusive. Here, we demonstrated that preferential accumulation of peroxidized phospholipids and loss of the antioxidant enzyme glutathione peroxidase 4 (GPX4) were responsible for vulnerability of midbrain dopaminergic neurons and progressive motor dysfunctions in a mouse model of PD. We also established a mechanism wherein iron-induced dopamine oxidation modified GPX4, thereby rendering it amenable to degradation via the ubiquitin-proteasome pathway. In conclusion, this study unraveled what we believe to be a novel pathway for dopaminergic neuron degeneration during PD pathogenesis, driven by dopamine-induced loss of antioxidant GPX4 activity.